Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3350782
Max Phase: Preclinical
Molecular Formula: C72H102N13O10S3+
Molecular Weight: 1405.89
Molecule Type: Small molecule
Associated Items:
ID: ALA3350782
Max Phase: Preclinical
Molecular Formula: C72H102N13O10S3+
Molecular Weight: 1405.89
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCN(CC)c1ccc2c(-c3ccc(S(=O)(=O)NCCCCCCCCCCCCNC(=O)NCCCC[C@H](NC(=O)Cc4csc(=N)n4C)C(=O)N[C@@H](Cc4cn(Cc5ccccc5)cn4)C(=O)NC4CC[N+](C)(C)CC4)cc3S(=O)(=O)[O-])c3ccc(=[N+](CC)CC)cc-3oc2c1
Standard InChI: InChI=1S/C72H101N13O10S3/c1-8-83(9-2)55-30-33-59-64(44-55)95-65-45-56(84(10-3)11-4)31-34-60(65)68(59)61-35-32-58(47-66(61)98(92,93)94)97(90,91)77-40-25-19-17-15-13-12-14-16-18-24-38-74-72(89)75-39-26-23-29-62(79-67(86)46-57-50-96-71(73)81(57)5)69(87)80-63(70(88)78-53-36-41-85(6,7)42-37-53)43-54-49-82(51-76-54)48-52-27-21-20-22-28-52/h20-22,27-28,30-35,44-45,47,49-51,53,62-63,73,77H,8-19,23-26,29,36-43,46,48H2,1-7H3,(H4-2,74,75,78,79,80,86,87,88,89,92,93,94)/p+1/t62-,63-/m0/s1
Standard InChI Key: WBBOIFYOAYRKBH-NTGUUYCISA-O
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1405.89 | Molecular Weight (Monoisotopic): 1404.7029 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Margathe JF, Iturrioz X, Alvear-Perez R, Marsol C, Riché S, Chabane H, Tounsi N, Kuhry M, Heissler D, Hibert M, Llorens-Cortes C, Bonnet D.. (2014) Structure-activity relationship studies toward the discovery of selective apelin receptor agonists., 57 (7): [PMID:24625069] [10.1021/jm401789v] |
Source(1):